Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
Phase 4
Completed
- Conditions
- Severe Obesity
- Interventions
- Registration Number
- NCT02876484
- Lead Sponsor
- Hvidovre University Hospital
- Brief Summary
The purpose of this study is to examine the effects of bile acid and bile acids sequestrants on GLP-1 Secretion, during a meal, in patients after Roux-en-Y gastric bypass.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Uncomplicated RYGB performed minimum 3 months prior to the study.
- Fasting plasma glucose < 7,0 mM, HbA1c < 48 mmol/mol 3 months after RYGB
Exclusion Criteria
- Fasting plasma glucose > 7,0 mM, HbA1c > 48 mmol/mol 3 months after RYGB.
- Dysregulated thyroid diseases, use of antithyroid treatment.
- Late diabetic complications as retinopathy, renal insufficiency, neuropathy or previous pancreatitis.
- Complications to RYGB. Documented reactive hypoglycaemia, severe dumping (vomiting, diarrhea, severe abdominal pain after food intake).
- Cholecystectomy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo Water Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. 25 ml water Chenodeoxycholic Acid Chenodeoxycholic Acid Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Chenodeoxycholic acid (1250 mg) mixed in 25 ml yoghurt Colesevelam Colesevelam Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt. Colesevelam x 2 Colesevelam plus (on another study day) 3,75 g colesevelam administered the evening before the experiment. Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt.
- Primary Outcome Measures
Name Time Method GLP-1 secretion (evaluated by iAUC) -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes after mixed meal
- Secondary Outcome Measures
Name Time Method Insulin secretion -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes PYY secretion -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes Bile acids/FGF19 concentrations -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes Glucose levels -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes PCM levels Baseline, 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, 240 minutes CCK secretion 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes Total bile acid secretion 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes Appetite measurements (VAS-score) 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes C-peptide secretion Baseline, 0, 5, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes Glucagon secretion Baseline, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes GIP secretion 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes Ghrelin 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes
Trial Locations
- Locations (1)
Hvidovre University Hospital
🇩🇰Hvidovre, Denmark